A Randomized, Placebo‐Controlled Trial to Assess the Effects of 8 Weeks of Administration of GSK256073, a Selective GPR109A Agonist, on High‐Density Lipoprotein Cholesterol in Subjects With Dyslipidemia-Reference-Cited by-同舟云学术

A Randomized, Placebo‐Controlled Trial to Assess the Effects of 8 Weeks of Administration of GSK256073, a Selective GPR109A Agonist, on High‐Density Lipoprotein Cholesterol in Subjects With Dyslipidemia

Published:2019-10 Issue:7 Volume:8 Page:871-883
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:Clinical Pharmacology in Drug Development

Author:

Olson Eric J.¹,Mahar Kelly M.²,Haws Thomas F.¹,Fossler Michael J.²,Gao Feng³,Gouville Anne‐Charlotte⁴,Sprecher Dennis L.¹,Lepore John J.¹

Affiliation:

1. Clinical Pharmacology and Experimental MedicineGlaxoSmithKline Collegeville PA USA

2. Clinical Pharmacology, Modeling and SimulationGlaxoSmithKline Collegeville PA USA

3. Clinical Statistics, Metabolic Pathways and Cardiovascular UnitGlaxoSmithKline Collegeville PA USA

4. GlaxoSmithKline LaboratoriesCentre de Recherche François Hyafil Les Ulis Cedex France

Funder

GlaxoSmithKline

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpdd.704

Reference27 articles.

1. Nicotinic acid: the broad-spectrum lipid drug. A 50th anniversary review

2. PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect

3. Molecular Identification of High and Low Affinity Receptors for Nicotinic Acid

4. The nicotinic acid receptor–a new mechanism for an old drug

5. Metabolic Effects of Suppression of Nonesterified Fatty Acid Levels With Acipimox in Obese NIDDM Subjects

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple recent HCAR2 structures demonstrate a highly dynamic ligand binding and G protein activation mode;Nature Communications;2024-06-25

2. Anthranilic Acid, a GPR109A Agonist, and Schizophrenia;International Journal of Tryptophan Research;2024-01

3. Signaling pathways in cancer metabolism: mechanisms and therapeutic targets;Signal Transduction and Targeted Therapy;2023-05-10

4. Physiological Associations between Vitamin B Deficiency and Diabetic Kidney Disease;Biomedicines;2023-04-11

5. Vitamin metabolism and requirements in chronic kidney disease and kidney failure;Nutritional Management of Renal Disease;2022